Are you Dr. Frangioni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Room Sl-B05
Boston, MA 02215Phone+1 617-667-0692Fax+1 617-667-0981
Summary
- Dr. John Frangioni, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is a Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1996
Harvard Medical SchoolClass of 1994
Certifications & Licensure
MA State Medical License 1996 - 2025
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2007
Clinical Trials
- Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer Start of enrollment: 2008 Jul 01
- Objective Flap Assessment During Reconstructive Surgery Start of enrollment: 2009 Jun 01
- Tissue Oxygenation Measurements With Modulated Light (S-FLARE) Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsuPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgeryMartin C. Boonstra, Pieter B A A van Driel, Danny M. van Willigen, Marieke A. Stammes, Hendrica A.J.M. Prevoo
Oncotarget. 2015-03-29 - 2719 citationsRenal clearance of quantum dots.Hak Soo Choi, Wenhao Liu, Preeti Misra, Eiichi Tanaka, John P. Zimmer
Nature Biotechnology. 2007-09-23 - 234 citationsSynthesis and In Vivo Fate of Zwitterionic Near-Infrared FluorophoresHak Soo Choi, Khaled Nasr, Sergey Alyabyev, Dina Feith, Jeong Heon Lee
Angewandte Chemie. 2011-07-04
Grant Support
- Image-Guided Surgery Of Endocrine Glands And Their Tumors Using NEAR-INFRARED FLUNational Institute Of Biomedical Imaging And Bioengineering2010–2012
- Ultra-Low Background NIR Fluorophores For In Vivo Imaging And Image-Guided SurgerNational Institute Of Biomedical Imaging And Bioengineering2010–2011
- Spatially-Modulated NEAR-INFRARED Light For Image-Guided Oncologic SurgeryNational Center For Research Resources2009–2011
- A Platform For Cancer Biomarker Validation: Image Fusion Using NIR FluorescenceNational Cancer Institute2009–2011
- Intraoperative NEAR-INFRARED Fluorescence ImagingNational Cancer Institute2005–2011
- A Mini-Cyclotron Facility To Support Cancer Research At The Bidmc/HmsNational Center For Research Resources2010
- NIR Fluorescent SLN Mapping For Breast CancerNational Cancer Institute2008–2009
- Spatially Modulated NEAR-INFRARED Light For Image-Guided Cancer SurgeryNational Cancer Institute2007–2009
- Objective FLAP Assessment During Reconstructive SurgeryNational Institute Of Biomedical Imaging And Bioengineering2006–2009
- FLEX TM Micropet/Spect/Ct To Support Cancer Research At Harvard Medical SchoolNational Center For Research Resources2006
- FLEX TM Micropet/Spect/Ct To Support Cancer RES At Harvard Med:Hei:Breast CancerNational Center For Research Resources2006
- FLEX TM Micropet/Spect/Ct To Support Cancer RES At Harvard Med:Hei: CancerNational Center For Research Resources2006
- FLEX TM Micropet/Spect/Ct To Support Cancer RES Harvard Med:Hei:Prostate CancerNational Center For Research Resources2006
- NEAR-INFRARED Quantum DOTS For In Vivo ImagingNational Institute Of Biomedical Imaging And Bioengineering2003–2006
- Improved Optical Sub-Systems For In Vivo Cancer ImagingNational Cancer Institute2004–2005
- Low-Molecular Weight Ligands For Prostate CancerNational Cancer Institute2002–2003
- NEAR-INFRARED Quantum DOTS For In Vivo ImagingNational Institute Of Biomedical Imaging And Bioengineering2002
- Molecular Imaging Of Advanced Bladder CancerNational Cancer Institute2001–2002
- Low-Molecular Weight Ligands For Prostate CancerNational Cancer Institute2000–2001
